Furthermore, drug combinations targeting lipid metabolism, such as inhibiting cholesterol acetylation (ACAT/SOAT), can enhance the sensitivity of melanoma cells to BRAF inhibitors by inducing ferroptosis [11]. Here, BRAF is linked to melanoma.